• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

比较肝细胞癌患者存在和不存在睡眠障碍的差异及决定因素。

Comparison of differences and determinants between presence and absence of sleep disturbance in hepatocellular carcinoma patients.

机构信息

Department of Nursing, Chang Gung Medical Foundation, Chang Gung Memorial Hospital at Lin-Kou, Taiwan.

出版信息

Cancer Nurs. 2011 Sep-Oct;34(5):354-60. doi: 10.1097/NCC.0b013e3182037bf3.

DOI:10.1097/NCC.0b013e3182037bf3
PMID:21242769
Abstract

BACKGROUND

Hepatocellular carcinoma patients often experience sleep disturbance after undergoing transcatheter arterial chemoembolization (TACE).

OBJECTIVE

The objectives of this study were to (1) examine and compare symptom distress, depression, and sleep quality in hepatocellular carcinoma patients undergoing TACE with sleep disturbance versus without sleep disturbance and (2) examine the determinants of sleep disturbance in these patients.

METHODS

Hepatocellular carcinoma patients undergoing TACE were recruited. The patients were evaluated 1 week (T1) and 1 month (T2) after receiving TACE in terms of performance status, symptom distress, depression (T1), and sleep disturbance (T2). Logistic regression was used to determine the predictive factors of sleep disturbance.

RESULTS

Patients with sleep disturbance reported significantly higher overall symptom distress and depression and lower sleep quality than patients without sleep disturbance. The 5 leading causes of symptom distress in both groups were fatigue, pain, poor appetite, chest tightness, and fever. Older age, greater symptom distress, and higher levels of depression were significantly associated with sleep disturbance.

CONCLUSIONS

The results of this study show significant associations among symptom distress, depression at baseline, and sleep problems 1 month after undergoing TACE. Clinicians should be aware of the possibility of lasting sleep disturbance in hepatocellular carcinoma patients undergoing TACE.

IMPLICATIONS FOR PRACTICE

In clinical care, symptom management, psychological consultation, and relaxation training may promote sleep quality.

摘要

背景

肝细胞癌患者在接受经导管动脉化疗栓塞(TACE)后常出现睡眠障碍。

目的

本研究旨在(1)比较并比较 TACE 术后有睡眠障碍和无睡眠障碍的肝细胞癌患者的症状困扰、抑郁和睡眠质量;(2)探讨这些患者睡眠障碍的决定因素。

方法

招募接受 TACE 的肝细胞癌患者。在接受 TACE 后 1 周(T1)和 1 个月(T2),评估患者的表现状态、症状困扰、抑郁(T1)和睡眠障碍(T2)。采用逻辑回归确定睡眠障碍的预测因素。

结果

有睡眠障碍的患者报告的总体症状困扰、抑郁和睡眠质量明显低于无睡眠障碍的患者。两组中导致症状困扰的 5 个主要原因是疲劳、疼痛、食欲不振、胸闷和发热。年龄较大、症状困扰较大和抑郁程度较高与睡眠障碍显著相关。

结论

本研究结果表明,TACE 后 1 个月,症状困扰、基线时的抑郁与睡眠问题之间存在显著关联。临床医生应注意 TACE 后肝细胞癌患者可能存在持续的睡眠障碍。

实践意义

在临床护理中,症状管理、心理咨询和放松训练可能会促进睡眠质量。

相似文献

1
Comparison of differences and determinants between presence and absence of sleep disturbance in hepatocellular carcinoma patients.比较肝细胞癌患者存在和不存在睡眠障碍的差异及决定因素。
Cancer Nurs. 2011 Sep-Oct;34(5):354-60. doi: 10.1097/NCC.0b013e3182037bf3.
2
The mediating effects of depression on sleep disturbance and fatigue: symptom clusters in patients with hepatocellular carcinoma.抑郁对睡眠障碍和疲劳的中介作用:肝细胞癌患者的症状群。
Cancer Nurs. 2009 Sep-Oct;32(5):398-403. doi: 10.1097/NCC.0b013e3181ac6248.
3
[Quality of life of primary hepatocellular carcinoma patients after radiofrequency ablation].[原发性肝细胞癌患者射频消融术后的生活质量]
Ai Zheng. 2005 Jul;24(7):827-33.
4
The safety and efficacy of transcatheter arterial chemoembolization in the treatment of patients with hepatocellular carcinoma and main portal vein obstruction. A prospective controlled study.经导管动脉化疗栓塞术治疗肝细胞癌合并门静脉主干阻塞患者的安全性和有效性:一项前瞻性对照研究。
Cancer. 1997 Jun 1;79(11):2087-94.
5
Symptom clusters and symptom interference of HCC patients undergoing TACE: a cross-sectional study in China.接受 TACE 治疗的 HCC 患者的症状群及症状干扰:中国的一项横断面研究。
Support Care Cancer. 2013 Feb;21(2):475-83. doi: 10.1007/s00520-012-1541-5. Epub 2012 Jul 20.
6
Renal failure in patients with hepatocellular carcinoma and ascites undergoing transarterial chemoembolization.肝癌合并腹水患者行经肝动脉化疗栓塞术后发生肾衰竭。
Liver Int. 2010 Jan;30(1):77-84. doi: 10.1111/j.1478-3231.2009.02128.x. Epub 2009 Oct 8.
7
Risk of hepatitis B exacerbation is low after transcatheter arterial chemoembolization therapy for patients with HBV-related hepatocellular carcinoma: report of a prospective study.经动脉化疗栓塞治疗乙肝相关肝细胞癌患者后乙肝病情加重的风险较低:一项前瞻性研究报告
Am J Gastroenterol. 2005 Oct;100(10):2194-200. doi: 10.1111/j.1572-0241.2005.00232.x.
8
Transcatheter arterial chemoembolization (TACE) in hepatocellular carcinoma (HCC): the role of angiogenesis and invasiveness.经动脉化疗栓塞术(TACE)在肝细胞癌(HCC)中的应用:血管生成与侵袭性的作用
Am J Gastroenterol. 2008 Apr;103(4):914-21. doi: 10.1111/j.1572-0241.2007.01712.x. Epub 2008 Jan 2.
9
Intraarterial lidocaine administration for relief of pain resulting from transarterial chemoembolization of hepatocellular carcinoma: its effectiveness and optimal timing of administration.经动脉注射利多卡因缓解肝细胞癌经动脉化疗栓塞所致疼痛:其有效性及最佳给药时机
Cardiovasc Intervent Radiol. 2001 Nov-Dec;24(6):368-71. doi: 10.1007/s00270-001-0073-z. Epub 2001 Nov 8.
10
[A comparison of patients with hepatocellular carcinoma between a short-term (less than 6 months) survival group and a long-term (over 24 months) survival group after treatment with transcatheter arterial chemoembolization].经导管动脉化疗栓塞治疗后短期(少于6个月)生存组与长期(超过24个月)生存组肝细胞癌患者的比较
Taehan Kan Hakhoe Chi. 2002 Jun;8(2):189-200.

引用本文的文献

1
Lifestyle factors in hepatocellular carcinoma: From pathogenesis to prognosis.肝细胞癌中的生活方式因素:从发病机制到预后
World J Clin Oncol. 2025 Jul 24;16(7):107723. doi: 10.5306/wjco.v16.i7.107723.
2
Sleep quality trajectories and their relationship with quality of life in patients with hepatocellular carcinoma: a prospective cohort study.肝细胞癌患者的睡眠质量轨迹及其与生活质量的关系:一项前瞻性队列研究。
Support Care Cancer. 2025 May 16;33(6):476. doi: 10.1007/s00520-025-09518-2.
3
Various types of stress and greater use of disengagement coping are associated with worse sleep disturbance in oncology patients undergoing chemotherapy.
各种类型的压力和更多地使用逃避应对方式与正在接受化疗的肿瘤患者睡眠障碍恶化有关。
Stress Health. 2024 Feb;40(1):e3279. doi: 10.1002/smi.3279. Epub 2023 Jun 2.
4
Global prevalence of depression and anxiety in patients with hepatocellular carcinoma: Systematic review and meta-analysis.全球原发性肝癌患者的抑郁和焦虑患病率:系统评价和荟萃分析。
Clin Mol Hepatol. 2022 Oct;28(4):864-875. doi: 10.3350/cmh.2022.0136. Epub 2022 Jul 25.
5
Challenges of advanced hepatocellular carcinoma.晚期肝细胞癌的挑战
World J Gastroenterol. 2016 Sep 14;22(34):7645-59. doi: 10.3748/wjg.v22.i34.7645.
6
Age differences in fatigue, decrements in energy, and sleep disturbance in oncology patients receiving chemotherapy.接受化疗的肿瘤患者在疲劳、能量下降和睡眠障碍方面的年龄差异。
Eur J Oncol Nurs. 2016 Aug;23:115-23. doi: 10.1016/j.ejon.2016.07.002. Epub 2016 Jul 15.
7
Effects of acupressure on fatigue and depression in hepatocellular carcinoma patients treated with transcatheter arterial chemoembolization: a quasi-experimental study.按压穴位对经导管动脉化疗栓塞治疗肝细胞癌患者疲劳和抑郁的影响:一项准实验研究。
Evid Based Complement Alternat Med. 2015;2015:496485. doi: 10.1155/2015/496485. Epub 2015 Feb 23.
8
Systematic review of sleep disorders in cancer patients: can the prevalence of sleep disorders be ascertained?癌症患者睡眠障碍的系统评价:能否确定睡眠障碍的患病率?
Cancer Med. 2015 Feb;4(2):183-200. doi: 10.1002/cam4.356. Epub 2014 Nov 30.